Content about Glaucoma

March 13, 2014

Perrigo announced the launch of methazolamide tablets, the generic version of Neptazane tablets. The product is a component of the rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates last year.

DUBLIN — Perrigo announced the launch of methazolamide tablets, the generic version of Neptazane tablets. The product is a component of the rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its affiliates last year.

May 13, 2013

New Jersey Gov. Chris Christie signed legislation into law that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

TRENTON, N.J. — New Jersey Gov. Chris Christie signed legislation into law Monday that will allow patients using prescription eye drops to get early refills in order to prevent interruptions in therapy.

April 22, 2013

The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

BASEL, Switzerland — The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

April 3, 2012

Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

PARSIPPANY, N.J. — Watson is challenging the patent protection on two eye drugs made by Allergan, the generic drug maker said Tuesday.

Watson announced that it had filed with the Food and Drug Administration for generic versions of Allergan's Lumigan and Latisse (bimatoprost) ophthalmic solution. The products contain the same active ingredient in the 0.01% and 0.03% strengths, respectively, and are used to reduce pressure within the eye in patients with open-angle glaucoma or ocular hypertension.

February 27, 2012

A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

PHOENIX — A division of specialty pharmacy provider The Apothecary Shops has become the exclusive distributor of a drug used in glaucoma surgery, the company said.

Apothecary Shop Wholesale has received exclusive distribution rights for Mobius Therapeutics' drug Mitosol (mitomycin), which the Food and Drug Administration approved earlier this month.

August 19, 2011

Americans that suffer from diabetes and/or hypertension are at risk of developing a common type of glaucoma, according to researchers at the University of Michigan Kellogg Eye Center.

NEW YORK — Americans that suffer from diabetes and/or hypertension are at risk of developing a common type of glaucoma, according to researchers at the University of Michigan Kellogg Eye Center.

July 8, 2011

American Regent has launched a generic drug for relieving pressure inside the eye, the company said.

SHIRLEY, N.Y. — American Regent has launched a generic drug for relieving pressure inside the eye, the company said.

American Regent announced the availability of latanoprost ophthalmic solution in the 0.005% strength.

The drug is a generic version of Pfizer’s Xalatan and is used to treat such conditions as glaucoma and ocular hypertension.

March 9, 2011

The Food and Drug Administration has accepted an approval application from Merck for a drug to treat eye diseases, Merck said Wednesday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has accepted an approval application from Merck for a drug to treat eye diseases, Merck said Wednesday.

Merck is seeking approval for Saflutan (tafluprost) ophthalmic solution, an investigational drug for relieving eye pressure in patients with glaucoma and ocular hypertension.

September 6, 2010

Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a...

MORRISTOWN, N.J. Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a version of a drug used to treat eye diseases, Watson said Tuesday.

August 31, 2010

Allergan's optimized reformulation of Lumigan has received approval from the Food and Drug Administration, the...

IRVINE, Calif. Allergan's optimized reformulation of Lumigan has received approval from the Food and Drug Administration, the drug maker said Wednesday.

Lumigan 0.01% (bimatoprost ophthalmic solution) is a first-line therapy indicated for the reduction of elevated intraocular pressure with open-angle glaucoma or ocular hypertension, Allergan said. Lumigan 0.01% will be available in fourth quarter 2010 as the newest addition to Allergan’s comprehensive glaucoma portfolio.

 

July 5, 2010

Fera Pharmaceuticals has launched an oral preventive treatment for glaucoma, Fera said Friday....

March 8, 2010

Aton Pharma has launched an authorized generic of a drug for glaucoma and ocular hypertension,...

January 27, 2010

The British subsidiary of Teva Pharmaceutical Industries has launched a treatment for intra-ocular pressure resulting...

January 3, 2010

With an eye to the future, Novartis brass envisions a growth arena driven by the...

NEW YORK With an eye to the future, Novartis brass envisions a growth arena driven by the aging Boomer population — eye care, along with all of the products, medicines and surgeries associated with eye care.

September 30, 2007

PharmaCentra, a marketing firm that provides customized healthcare management programs for the pharmaceutical industry, will...